Highlights
1 patentProfile claimed by owner
About
Advanced Lipid-based Platform
Revium Rx develops advanced delivery systems for a variety of indications. Its platform expands the therapeutic horizons of hard-to-treat diseases by enhancing, improving and unleashing the potential of encapsulated therapeutics. Revium’s current pipeline encompasses antibiotics for antimicrobial-resistant bacteria, immune checkpoint inhibitor adjuvant for solid tumors, and a novel immunization platform.
Identity
| Name | Revium Rx |
|---|---|
| Slug | revium-rx |
| Former names | Revium Recovery Inc. |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4N-14boJDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Herzliya |
| HQ address | HaMenofim Street 10, Herzliya, Israel |
Web & social
| Website | https://www.reviumrx.com |
|---|---|
| https://www.linkedin.com/company/106169093 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesHealthcarePatients
Business models
B2B
Tags
cancer-therapytherapeuticsimmunotherapydrug-deliverypharmaceuticals
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}